5-ht3 receptor antagonists for dyskinesia

Details 5-ht3 receptor antagonists for dyskinesia 5-ht3 receptor antagonists for dyskinesia

A - Human Necessities

61

K

A61K 31/415 (2006.01) A61K 31/00 (2006.01) A61K 31/34 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4164 (2006.01) A61K 31/4184 (2006.01) A61K 31/437 (2006.01) A61K 31/46 (2006.01) A61K 31/47 (2006.01) A61K 31/4725 (2006.01) A61K 31/473 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/535 (2006.01) A61K 31/60 (2006.01) A61K 31/66 (2006.01)

Patent

CA 2231887

The invention provides the use of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivative thereof for use in the treatment of dyskinesia.

Utilisation d'un antagoniste du récepteur de 5-HT¿3? ou d'un dérivé pharmaceutiquement acceptable de celui-ci dans le traitement de la dyskinésie.

Affiliated with

Also associated with

Rating

5-ht3 receptor antagonists for dyskinesia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-ht3 receptor antagonists for dyskinesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ht3 receptor antagonists for dyskinesia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1917392